Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:e20-e25
Published online before print January 26, 2006, doi: 10.1161/01.RES.0000205765.28940.93
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/3/e20    most recent
01.RES.0000205765.28940.93v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedrich, E. B.
Right arrow Articles by Werner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedrich, E. B.
Right arrow Articles by Werner, N.
Related Collections
Right arrow Cell biology/structural biology
Right arrow Other arteriosclerosis
Right arrow Other Vascular biology
(Circulation Research. 2006;98:e20.)
© 2006 American Heart Association, Inc.


UltraRapid Communication

CD34/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities

Erik B. Friedrich, Katrin Walenta, John Scharlau, Georg Nickenig, Nikos Werner

From the Department for Internal Medicine III (E.B.F., K.W., J.S.), University Hospital of the Saarland; and Department for Internal Medicine II (G.N., N.W.), University Hospital Bonn, Germany.

Correspondence to Prof Dr Georg Nickenig, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. E-mail georg.nickenig{at}ukb.uni-bonn.de

Our goal was to identify functionally important subpopulations within the heterogenous group of endothelial progenitor cells (EPC). Fluorescence-activated cell sorter analysis of CD133+ progenitor cells revealed the presence of CD34+ and CD34 subpopulations. CD34/133+ progenitors differentiate into CD34+/133+ EPC, adhere more potently than these in response to SDF-1, and rapidly home to sites of limb ischemia in human volunteers. In human coronary atherectomy samples, fewer CD34/133+ than CD34+/133+ EPC are present in stable plaques, whereas cell numbers increase with a reversion of the ratio in unstable lesions. In CD34/133+ EPC-injected nude mice, more transplanted cells coexpressing endothelial markers home to carotid artery lesion endothelium than in CD34+/133+-injected mice. In the former, lesions were smaller and reendothelialization higher than in the latter. We identified a new CD34/133+ EPC subpopulation, which is apparently a precursor of "classical" CD34+/133+ EPC, and functionally more potent than these with respect to homing and vascular repair.


Key Words: endothelial progenitor cells • CD34/CD133 • arterial injury • reendothelialization • atherosclerosis




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
C. Nesselmann, W. Li, N. Ma, and G. Steinhoff
Stem cell-mediated neovascularization in heart repair
Therapeutic Advances in Cardiovascular Disease, February 1, 2010; 4(1): 27 - 42.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
P. Ebner, F. Picard, J. Richter, E. Darrelmann, M. Schneider, B.-E. Strauer, and M. Brehm
Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE
Rheumatology, January 1, 2010; 49(1): 63 - 72.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
Z. Boda, M. Udvardy, K. Razso, K. Farkas, J. Toth, L. Jambor, Z. Olah, P. Ilonczai, M. Szarvas, J. Kappelmayer, et al.
Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger's Disease
Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 552 - 560.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Yao, A. L. Firth, R. S. Sacks, A. Ogawa, W. R. Auger, P. F. Fedullo, M. M. Madani, G. Y. Lin, N. Sakakibara, P. A. Thistlethwaite, et al.
Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L870 - L878.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-H. Chen, R. A.F. Dixon, L.-Y. Ke, and J. T. Willerson
Vascular Progenitor Cells in Diabetes Mellitus: Roles of Wnt Signaling and Negatively Charged Low-Density Lipoprotein
Circ. Res., May 8, 2009; 104(9): 1038 - 1040.
[Full Text] [PDF]


Home page
Vasc MedHome page
D. P Sieveking and M. K. Ng
Cell therapies for therapeutic angiogenesis: back to the bench
Vascular Medicine, May 1, 2009; 14(2): 153 - 166.
[Abstract] [PDF]


Home page
BloodHome page
Y. Feng, M. van Eck, E. Van Craeyveld, F. Jacobs, V. Carlier, S. Van Linthout, M. Erdel, M. Tjwa, and B. De Geest
Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer
Blood, January 15, 2009; 113(3): 755 - 764.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-S. Maeng, H.-J. Choi, J.-Y. Kwon, Y.-W. Park, K.-S. Choi, J.-K. Min, Y.-H. Kim, P.-G. Suh, K.-S. Kang, M.-H. Won, et al.
Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC{beta}2 axis
Blood, January 1, 2009; 113(1): 233 - 243.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Gossl, U. I. Modder, E. J. Atkinson, A. Lerman, and S. Khosla
Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis
J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1314 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. E. Thomas, R. Redgrave, M. S. Cunnington, P. Avery, B. D. Keavney, and H. M. Arthur
Circulating Endothelial Progenitor Cells Exhibit Diurnal Variation
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): e21 - e22.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Shantsila, T. Watson, H.-F. Tse, and G. Y.H. Lip
New insights on endothelial progenitor cell subpopulations and their angiogenic properties.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 669 - 671.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. Voo, J. Eggermann, M. Dunaeva, C. Ramakers-van Oosterhoud, and J. Waltenberger
Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction
Eur. Heart J., January 2, 2008; 29(2): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W Wojakowski, M Kucia, M Kazmierski, M Z Ratajczak, and M Tendera
Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?
Heart, January 1, 2008; 94(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Irwin, K. Helm, N. Campbell, M. Imamura, K. Fagan, J. Harral, M. Carr, K. A. Young, D. Klemm, S. Gebb, et al.
Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L941 - L951.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Erbs, A. Linke, V. Schachinger, B. Assmus, H. Thiele, K.-W. Diederich, C. Hoffmann, S. Dimmeler, T. Tonn, R. Hambrecht, et al.
Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction: The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial
Circulation, July 24, 2007; 116(4): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Timmermans, F. Van Hauwermeiren, M. De Smedt, R. Raedt, F. Plasschaert, M. L. De Buyzere, T. C. Gillebert, J. Plum, and B. Vandekerckhove
Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1572 - 1579.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B. Scheller, U. Speck, and M. Bohm
Prevention of restenosis: is angioplasty the answer?
Heart, May 1, 2007; 93(5): 539 - 541.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. P. Fadini, C. Agostini, and A. Avogaro
Endothelial progenitor cells and erectile dysfunction
Eur. Heart J., March 1, 2007; 28(5): 639 - 640.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Witkowski and J. M. Hagberg
Progenitor cells and age: can we fight aging with exercise?
J Appl Physiol, March 1, 2007; 102(3): 834 - 835.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. P. Fadini, S. Sartore, M. Albiero, I. Baesso, E. Murphy, M. Menegolo, F. Grego, S. Vigili de Kreutzenberg, A. Tiengo, C. Agostini, et al.
Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2140 - 2146.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, and S. Vigili de Kreutzenberg
Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population
Stroke, September 1, 2006; 37(9): 2277 - 2282.
[Abstract] [Full Text] [PDF]